Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Geriatric Assessment | 17 | 2023 | 1366 | 2.790 |
Why?
|
Hematologic Neoplasms | 8 | 2023 | 1800 | 1.800 |
Why?
|
Geriatrics | 4 | 2021 | 396 | 1.340 |
Why?
|
Veterans | 7 | 2023 | 2505 | 1.110 |
Why?
|
Frail Elderly | 11 | 2023 | 690 | 0.900 |
Why?
|
Thoracic Surgical Procedures | 2 | 2023 | 342 | 0.840 |
Why?
|
Thoracic Surgery | 3 | 2023 | 715 | 0.840 |
Why?
|
Neoplasms | 11 | 2023 | 21507 | 0.680 |
Why?
|
Patient Care Management | 1 | 2021 | 306 | 0.620 |
Why?
|
Medical Oncology | 5 | 2023 | 2217 | 0.600 |
Why?
|
Poetry as Topic | 1 | 2016 | 17 | 0.570 |
Why?
|
Aged | 41 | 2023 | 162698 | 0.470 |
Why?
|
Esophagectomy | 3 | 2022 | 447 | 0.470 |
Why?
|
Quality of Life | 3 | 2021 | 12640 | 0.450 |
Why?
|
Patient Care | 1 | 2018 | 638 | 0.420 |
Why?
|
Patient Dropouts | 1 | 2013 | 419 | 0.390 |
Why?
|
Multiple Myeloma | 3 | 2023 | 5147 | 0.390 |
Why?
|
Family Practice | 1 | 2013 | 516 | 0.370 |
Why?
|
Appointments and Schedules | 1 | 2013 | 415 | 0.350 |
Why?
|
Ambulatory Care Facilities | 2 | 2023 | 928 | 0.330 |
Why?
|
Disease Management | 1 | 2019 | 2448 | 0.320 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2023 | 3485 | 0.310 |
Why?
|
Activities of Daily Living | 4 | 2023 | 2410 | 0.310 |
Why?
|
Esophageal Neoplasms | 3 | 2022 | 1575 | 0.300 |
Why?
|
Survivors | 1 | 2018 | 2280 | 0.300 |
Why?
|
Decision Making | 1 | 2021 | 3854 | 0.300 |
Why?
|
Motivation | 1 | 2016 | 1965 | 0.290 |
Why?
|
Gait | 2 | 2023 | 781 | 0.270 |
Why?
|
Patient Discharge | 1 | 2018 | 3286 | 0.270 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3021 | 0.260 |
Why?
|
Patient Compliance | 2 | 2021 | 2679 | 0.240 |
Why?
|
Patient Readmission | 1 | 2018 | 3106 | 0.240 |
Why?
|
Cognition | 1 | 2021 | 6686 | 0.230 |
Why?
|
Patient Education as Topic | 1 | 2013 | 2275 | 0.230 |
Why?
|
Humans | 44 | 2023 | 739398 | 0.220 |
Why?
|
Vital Signs | 1 | 2023 | 141 | 0.200 |
Why?
|
Age Factors | 6 | 2021 | 18349 | 0.190 |
Why?
|
Pain | 1 | 2016 | 4923 | 0.190 |
Why?
|
Aged, 80 and over | 11 | 2023 | 57650 | 0.190 |
Why?
|
Technology | 1 | 2023 | 299 | 0.190 |
Why?
|
Risk Assessment | 2 | 2019 | 23294 | 0.190 |
Why?
|
Multiple Organ Failure | 1 | 2023 | 385 | 0.190 |
Why?
|
Hematology | 1 | 2023 | 217 | 0.180 |
Why?
|
Caregivers | 2 | 2023 | 2067 | 0.180 |
Why?
|
Breast Neoplasms | 2 | 2018 | 20676 | 0.180 |
Why?
|
Comorbidity | 4 | 2023 | 10362 | 0.170 |
Why?
|
Population Dynamics | 1 | 2021 | 300 | 0.170 |
Why?
|
Prognosis | 5 | 2023 | 28901 | 0.160 |
Why?
|
Health Services for the Aged | 1 | 2020 | 268 | 0.150 |
Why?
|
Risk Adjustment | 1 | 2021 | 591 | 0.150 |
Why?
|
Morbidity | 2 | 2020 | 1763 | 0.150 |
Why?
|
Dexamethasone | 1 | 2023 | 1948 | 0.140 |
Why?
|
Hand Strength | 1 | 2019 | 441 | 0.140 |
Why?
|
Medicine in Literature | 1 | 2016 | 31 | 0.140 |
Why?
|
International Classification of Diseases | 1 | 2021 | 867 | 0.130 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2018 | 358 | 0.120 |
Why?
|
Podocytes | 1 | 2018 | 392 | 0.120 |
Why?
|
Lung Neoplasms | 3 | 2022 | 12985 | 0.110 |
Why?
|
Infection Control | 1 | 2020 | 968 | 0.110 |
Why?
|
Mechanotransduction, Cellular | 1 | 2018 | 538 | 0.110 |
Why?
|
Nursing Homes | 1 | 2019 | 1029 | 0.110 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3143 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3248 | 0.100 |
Why?
|
Needs Assessment | 1 | 2018 | 1145 | 0.100 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 11410 | 0.100 |
Why?
|
United States | 9 | 2023 | 69573 | 0.100 |
Why?
|
Hospitalization | 2 | 2022 | 10208 | 0.100 |
Why?
|
Critical Illness | 1 | 2023 | 2656 | 0.090 |
Why?
|
Intensive Care Units | 2 | 2023 | 3672 | 0.090 |
Why?
|
Glomerular Filtration Rate | 1 | 2018 | 2184 | 0.090 |
Why?
|
Pandemics | 2 | 2020 | 8274 | 0.090 |
Why?
|
Polypharmacy | 2 | 2022 | 290 | 0.090 |
Why?
|
Hospitals | 1 | 2023 | 3916 | 0.090 |
Why?
|
Referral and Consultation | 1 | 2022 | 3514 | 0.080 |
Why?
|
Patient Selection | 1 | 2021 | 4211 | 0.080 |
Why?
|
Quality Improvement | 2 | 2021 | 3730 | 0.080 |
Why?
|
Survival Rate | 2 | 2021 | 12761 | 0.080 |
Why?
|
Social Support | 1 | 2018 | 2112 | 0.080 |
Why?
|
Terminal Care | 1 | 2019 | 1688 | 0.080 |
Why?
|
United States Department of Veterans Affairs | 2 | 2022 | 873 | 0.080 |
Why?
|
Electronic Health Records | 1 | 2023 | 4426 | 0.070 |
Why?
|
Neoplasm Staging | 2 | 2021 | 10961 | 0.070 |
Why?
|
Proportional Hazards Models | 2 | 2020 | 12328 | 0.070 |
Why?
|
Massachusetts | 1 | 2019 | 8669 | 0.070 |
Why?
|
Urban Population | 1 | 2013 | 2014 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2021 | 4014 | 0.070 |
Why?
|
Female | 11 | 2023 | 378853 | 0.060 |
Why?
|
Medicare | 3 | 2022 | 6497 | 0.060 |
Why?
|
Socioeconomic Factors | 1 | 2018 | 7726 | 0.060 |
Why?
|
Telemedicine | 1 | 2021 | 2844 | 0.060 |
Why?
|
Length of Stay | 3 | 2022 | 6295 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5154 | 0.060 |
Why?
|
Adenocarcinoma | 1 | 2021 | 6318 | 0.060 |
Why?
|
Retrospective Studies | 8 | 2023 | 76631 | 0.060 |
Why?
|
Marital Status | 1 | 2023 | 435 | 0.050 |
Why?
|
Male | 10 | 2023 | 349022 | 0.050 |
Why?
|
Neoadjuvant Therapy | 2 | 2022 | 2688 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2016 | 13880 | 0.050 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2022 | 207 | 0.050 |
Why?
|
Medicaid | 1 | 2013 | 2711 | 0.050 |
Why?
|
Postoperative Complications | 4 | 2022 | 15194 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 2018 | 7626 | 0.040 |
Why?
|
Pneumonia, Aspiration | 1 | 2019 | 144 | 0.040 |
Why?
|
Thoracotomy | 1 | 2020 | 365 | 0.040 |
Why?
|
Dehydration | 1 | 2019 | 230 | 0.040 |
Why?
|
Middle Aged | 5 | 2022 | 212863 | 0.040 |
Why?
|
Carboplatin | 1 | 2021 | 800 | 0.040 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2020 | 279 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2019 | 38942 | 0.040 |
Why?
|
Program Development | 1 | 2021 | 1313 | 0.030 |
Why?
|
Prospective Studies | 1 | 2019 | 53037 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2021 | 2872 | 0.030 |
Why?
|
Urinary Tract Infections | 1 | 2019 | 766 | 0.030 |
Why?
|
Renal Insufficiency | 1 | 2019 | 803 | 0.030 |
Why?
|
Paclitaxel | 1 | 2021 | 1701 | 0.030 |
Why?
|
Internship and Residency | 1 | 2013 | 5761 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2021 | 2897 | 0.030 |
Why?
|
Hospice Care | 1 | 2019 | 671 | 0.030 |
Why?
|
Young Adult | 2 | 2020 | 56255 | 0.030 |
Why?
|
Infant | 1 | 2013 | 34923 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2021 | 5058 | 0.020 |
Why?
|
Adult | 4 | 2022 | 213394 | 0.020 |
Why?
|
Child, Preschool | 1 | 2013 | 40802 | 0.020 |
Why?
|
Adolescent | 2 | 2020 | 85405 | 0.020 |
Why?
|
Gene Expression | 1 | 2022 | 7788 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2023 | 5305 | 0.020 |
Why?
|
Time Factors | 2 | 2021 | 40050 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6516 | 0.020 |
Why?
|
Pneumonia | 1 | 2019 | 2102 | 0.020 |
Why?
|
Odds Ratio | 1 | 2019 | 9846 | 0.020 |
Why?
|
Sepsis | 1 | 2019 | 2571 | 0.020 |
Why?
|
Child | 1 | 2013 | 77033 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2022 | 62693 | 0.020 |
Why?
|
Risk Factors | 2 | 2023 | 71974 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2020 | 4365 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5272 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2022 | 10142 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7274 | 0.010 |
Why?
|
Algorithms | 1 | 2022 | 13872 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 24714 | 0.010 |
Why?
|
Animals | 1 | 2018 | 168368 | 0.000 |
Why?
|
Concepts
(141)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(57)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_